Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study

Abstract

Fatal heroin overdose has become a leading cause of death among injection drug users (IDUs). Several recent feasibility studies have concluded that naloxone distribution programs for heroin injectors should be implemented to decrease heroin overdose deaths, but there have been no prospective trials of such programs in North America. This pilot study was undertaken to investigate the safety and feasibility of training injection drug using partners to perform cardiopulmonary resuscitation (CPR) and administer naloxone in the event of heroin overdose. During May and June 2001, 24 IDUs (12 pairs of injection partners) were recruited from street settings in San Francisco. Participants took part in 8-hour training in heroin overdose prevention, CPR, and the use of naloxone. Following the intervention, participants were prospectively followed for 6 months to determine the number and outcomes of witnessed heroin overdoses, outcomes of participant interventions, and changes in participants’ knowledge of overdose and drug use behavior. Study participants witnessed 20 heroin overdose events during 6 months follow-up. They performed CPR in 16 (80%) events, administered naloxone in 15 (75%) and did one or the other in 19 (95%). All overdose victims survived. Knowledge about heroin overdose management increased, whereas heroin use decreased. IDUs can be trained to respond to heroin overdose emergencies by performing CPR and administering naloxone. Future research is needed to evaluate the effectiveness of this peer intervention to prevent fatal heroin overdose.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Sporer KA. Strategies for preventing heroin overdose. BMJ 2003;326:442–444.

    PubMed Central  PubMed  Article  Google Scholar 

  2. 2.

    Drucker E, Garfield J. Overdose trends in five US cities: 1988–1997. Paper presented at: Preventing Heroin Overdose: pragmatic approaches: January 13–14, 2000; Seattle, Washington, DC.

  3. 3.

    Latkin CA, Hua W, Tobin K. Social network correlates of self-reported non-fatal overdose. Drug Alcohol Depend. 2004;73:61–67.

    PubMed  Article  Google Scholar 

  4. 4.

    Davidson PJ, McLean RL, Kral AH, Gleghorn AA, Edlin BR, Moss AR. Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention. J Urban Health. 2003;80:261–273.

    PubMed Central  PubMed  Article  Google Scholar 

  5. 5.

    Burris S, Noreland J, Edlin B. Legal aspects of providing naloxone to heroin users in the United States. Int J Drug Policy. 2001;12:237–248.

    Article  Google Scholar 

  6. 6.

    Darke S, Zador D. Fatal heroin “overdose”: a review. Addiction. 1996;91:1765–1772.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Powis B, Strang J, Griffiths P, et al, Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction. 1999;94:471–478.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Strang J, Best D, Man L, Noble A, Gossop M. Peer-initiated. Int J Drug Policy. 2000;11:437–445.

    PubMed  Article  Google Scholar 

  9. 9.

    Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584–590.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Strang J, Powis B, Best D, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction. 1999;94:199–204.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Darke S, Hall W. The distribution of naloxone to heroin users. Addiction. 1997;92:1195–1199.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001;322:895–896.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  13. 13.

    Ronconi S. Prevention of overdoses among current heroin users in Torino Italy for the period 1995–1998. Paper presented at: Preventing Heroin Overdose: pragmatic approaches; January 13–14, 2000; Seattle, Washington, DC.

  14. 14.

    Bigg D. Data on take home naloxone are unclear but not condemnatory (letter). BMJ. 2002;324:678.

    PubMed Central  PubMed  Article  Google Scholar 

  15. 15.

    Baca C, Richards M, Grant KJ. Take-home naloxone to prevent deaths from opiate overdose [rapid response]. BMJ [serial online]. May 21, 2001. Available at: http://bmj.com/cgi/eletters/322/7291/895 14648.

  16. 16.

    Mountain D. Take home naloxone for opiate addicts. Big conclusions are drawn from little evidence. BMJ. 2001;323:934.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  17. 17.

    Ashworth AJ, Kidd A. Take home naloxone for opiate addicts. Apparent advantages may be balanced by hidden harms. BMJ. 2001;323:935.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Seal KH, Downing M, Kral AH, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose. J Urban Health. 2003;80:291–301.

    PubMed Central  PubMed  Article  Google Scholar 

  19. 19.

    Chicago Recovery Alliance. CRA’s opiate overdose prevention program 2002 and opiate overdose prevention/intervention training slide show [on-line]. Available at: http://www.anypositivechange.org/res.html.

  20. 20.

    Centers for Disease Control and Prevention. Transmission of hepatitis B and C viruses in outpatient settings—New York, Oklahoma, and Nebraska, 2000–2002, MMWR Morb Mortal Wkly Rep. 2003;52:901–906.

    Google Scholar 

  21. 21.

    SAS Release. Version 8.02. (1999–2001) by SAS Institute Inc., Cary, NC, USA.

  22. 22.

    Lenton SR, Hargreaves KM. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J Aust. 2000;173:260–263.

    CAS  PubMed  Google Scholar 

  23. 23.

    Dietze P, Cantwell K, Burgess S Bystander resuscitation attempts at heroin overdose: does it improve outcomes? Drug Alcohol Depend. 2002;67:213–218.

    PubMed  Article  Google Scholar 

  24. 24.

    Broadhead RS, Heckathorn DD, Weakliem DL, et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113:42–57.

    PubMed Central  PubMed  Google Scholar 

  25. 25.

    Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use. JAMA. 1992;268:2374–2375.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-repored recent drug use. Assessment. 1994;1:383–392.

    Google Scholar 

  27. 27.

    Cobb LA, Hallstrom AP. Community-based cardiopulmonary resuscitation. what have we learned? Ann N Y Acad Sci. 1982;382:330–342.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Brennan RT, Braslow A. Skill mastery in public CPR classes. Am J Emerg Med. 1998;16:653–657.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Becker LB, Ostander MP, Barrett J, Kondos GT. Outcome of CPR in a large metropolitan area—where are the survivors? Ann Emerg Med. 1991;20:355–361.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Pane GA, Salnes KA. A survey of participants in a mass CPR training course. Ann Emerg Med. 1987;16:1112–1116.

    CAS  PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Karen H. Seal.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Seal, K.H., Thawley, R., Gee, L. et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. J Urban Health 82, 303–311 (2005). https://doi.org/10.1093/jurban/jti053

Download citation

Keywords

  • Heroin
  • Heroin-related deaths
  • Injection drug use
  • Overdose
  • Prevention